Extract

- To demonstrate lot-to-lot consistency in terms of anti-gE humoral immunogenicity between three production lots of the HZ/su vaccine one month after the second dose (Month 3).

Inclusion criteria

• Herpes Zoster (HZ) and its related complications

Links

• ictrp
• euctr